1. Home
  2. TLS vs ENTA Comparison

TLS vs ENTA Comparison

Compare TLS & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.91

Market Cap

324.7M

Sector

Technology

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.23

Market Cap

378.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
ENTA
Founded
1969
1995
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.7M
378.0M
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
TLS
ENTA
Price
$4.91
$13.23
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$7.90
$20.40
AVG Volume (30 Days)
421.1K
146.0K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
31.51
29.93
EPS
0.03
N/A
Revenue
$164,805,000.00
$102,814,000.00
Revenue This Year
$18.72
$7.76
Revenue Next Year
$14.62
N/A
P/E Ratio
$155.33
N/A
Revenue Growth
52.21
16.48
52 Week Low
$2.37
$6.45
52 Week High
$8.36
$17.15

Technical Indicators

Market Signals
Indicator
TLS
ENTA
Relative Strength Index (RSI) N/A 44.64
Support Level N/A $11.92
Resistance Level N/A $13.98
Average True Range (ATR) 0.00 0.61
MACD 0.00 -0.06
Stochastic Oscillator 0.00 23.35

Price Performance

Historical Comparison
TLS
ENTA

About TLS Telos Corporation

Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: